Literature DB >> 33501968

To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era.

Maura Manion1, Niamh Lynn2, Luxin Pei1, Dima A Hammoud3, Elizabeth Laidlaw1, Gregg Roby1, Dorinda Metzger1, Yolanda Mejia4, Andrea Lisco1, Adrian Zelazny1, Steve Holland1, Marie-Louise Vachon5, Matthew Scherer6, Colm Bergin2, Irini Sereti1.   

Abstract

Mycobacterium  genavense is a challenging opportunistic pathogen to diagnose and manage in patients with human immunodeficiency virus (HIV). Persistent immunosuppression or protracted immune reconstitution inflammatory syndrome can lead to complicated clinical courses. We describe 3 cases of M. genavense in patients with HIV representing the spectrum between disease burden and strength of immune response.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Mycobacterium genavensezzm321990 ; HIV; IRIS

Year:  2021        PMID： 33501968      PMCID： PMC7840099          DOI： 10.1093/cid/ciaa753

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  Infection with a novel, unidentified mycobacterium.

Authors:  E C Böttger
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

2.  A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS.

Authors:  Denise C Hsu; Kimberly F Faldetta; Luxin Pei; Virginia Sheikh; Netanya S Utay; Gregg Roby; Adam Rupert; Anthony S Fauci; Irini Sereti
Journal:  Clin Infect Dis       Date:  2015-09-22       Impact factor: 9.079

3.  Fatal infection with a novel, unidentified mycobacterium in a man with the acquired immunodeficiency syndrome.

Authors:  B Hirschel; H R Chang; N Mach; P F Piguet; J Cox; J D Piguet; M T Silva; L Larsson; P R Klatser; J E Thole
Journal:  N Engl J Med       Date:  1990-07-12       Impact factor: 91.245

4.  Mycobacterium genavense in the Netherlands: an opportunistic pathogen in HIV and non-HIV immunocompromised patients. An observational study in 14 cases.

Authors:  W Hoefsloot; J van Ingen; E J G Peters; C Magis-Escurra; P N R Dekhuijzen; M J Boeree; D van Soolingen
Journal:  Clin Microbiol Infect       Date:  2012-03-22       Impact factor: 8.067

5.  Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.

Authors:  U Salzer; H M Chapel; A D B Webster; Q Pan-Hammarström; A Schmitt-Graeff; M Schlesier; H H Peter; J K Rockstroh; P Schneider; A A Schäffer; L Hammarström; B Grimbacher
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

6.  Mycobacterium genavense infections: a retrospective multicenter study in France, 1996-2007.

Authors:  Pierre Charles; Olivier Lortholary; Agnès Dechartres; Fahranoosh Doustdar; Jean Paul Viard; Marc Lecuit; Maria Cristina Gutierrez
Journal:  Medicine (Baltimore)       Date:  2011-07       Impact factor: 1.889

7.  Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients.

Authors:  M B Coyle; L C Carlson; C K Wallis; R B Leonard; V A Raisys; J O Kilburn; M Samadpour; E C Böttger
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

8.  Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study.

Authors:  M Pechère; M Opravil; A Wald; J P Chave; M Bessesen; A Sievers; R Hein; J von Overbeck; R A Clark; E Tortoli
Journal:  Arch Intern Med       Date:  1995-02-27

9.  Disseminated Mycobacterium genavense infection: clinical and microbiological features and response to therapy.

Authors:  M T Bessesen; J Shlay; B Stone-Venohr; D L Cohn; R R Reves
Journal:  AIDS       Date:  1993-10       Impact factor: 4.177

Review 10.  Mycobacterium genavense in AIDS patients, report of 24 cases in Italy and review of the literature.

Authors:  E Tortoli; F Brunello; A E Cagni; D Colombrita; D Dionisio; L Grisendi; V Manfrin; M Moroni; C Passerini Tosi; G Pinsi; C Scarparo; M T Simonetti
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082
View more
  1 in total

Review 1.  Host-directed immunotherapy of viral and bacterial infections: past, present and future.

Authors:  Robert S Wallis; Anne O'Garra; Alan Sher; Andreas Wack
Journal:  Nat Rev Immunol       Date:  2022-06-07       Impact factor: 108.555
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.